| Literature DB >> 29270435 |
Marcello De Fine1, Matteo Romagnoli2, Stefano Zaffagnini2, Giovanni Pignatti1.
Abstract
Sciatic nerve palsies are rare but potentially devastating complications, accounting for more than 90% of neurologic injuries following total hip replacement. A systematic literature screening was carried out searching papers evaluating an exclusive population of postarthroplasty sciatic nerve palsies to ascertain (1) the influence of limb lengthening itself on sciatic nerve palsy, (2) the most important risk factors, (3) the long-term prognosis, and (4) the outcomes of different treatments. Fourteen manuscripts were finally included. The wide prevalence of retrospective case series decreased the global methodological quality of the retrieved papers. A hazardous lengthening threshold cannot be surely identified. Developmental dysplasia of the hip and previous hip surgeries are the most frequently recognized risk factors. Rate of full nerve function restoration approximates two-thirds of the cases, independently of the extent of initial neural damage. Poor evidences are available about the best treatment strategy. Well-structured multicentric prospective comparative studies are needed to substantiate or contrast the finding of this review. Anyway, since the onset of palsies is probably due to a combination of individual factors, risk of nerve damage and potential for nerve recovery should be evaluated on an individual basis.Entities:
Mesh:
Year: 2017 PMID: 29270435 PMCID: PMC5705876 DOI: 10.1155/2017/8361071
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Figure 1Search strategy.
Available literature about postarthroplasty sciatic nerve injuries.
| Authors, year | Level of Evidence | GRACE score (number of items) | Topics assessed | Number of sciatic injuries |
|---|---|---|---|---|
| Weber et al., 1976 | IV | 2/11 | Prognosis, risk factors | 10 |
| Johanson et al., 1982 | IV | 3/11 | Lengthening | 34 |
| Edwards et al., 1987 | IV | 3/11 | Lengthening, prognosis | 23 |
| Schmalzried et al., 1991 | IV | 5/11 | Lengthening, prognosis, risk factors | 48 |
| Simon et al., 1993 | IV | 4/11 | Lengthening, prognosis | 16 |
| Nercessian et al., 1994 | IV | 8/11 | Lengthening, prognosis | 29 |
| Navarro et al., 1995 | IV | 5/11 | Prognosis, risk factors | 7 |
| Oldenburg et al., 1997 | IV | 4/11 | Prognosis, risk factors | 46 |
| Pekkarinen et al., 1999 | IV | 9/11 | Lengthening, prognosis, treatment, risk factors | 27 |
| Butt et al., 2005 | IV | 4/11 | Treatment | 6 |
| Farrell et al., 2005 | II | 9/11 | Prognosis, risk factors | 44 |
| Park et al., 2013 | II | 11/11 | Lengthening, prognosis, risk factors | 30 |
| Kyriacou et al., 2013 | IV | 5/11 | Treatment | 56 |
| Zappe et al., 2014 | IV | 8/11 | Prognosis | 9 |
Postarthroplasty sciatic nerve injuries and limb lengthening.
| Authors | Number of sciatic injuries | Average lengthening (cm) | Rate of lengthened hips | Rate of previous hip surgery |
|---|---|---|---|---|
| Johanson | 34 | N.A. | 5 limbs ≥ 2 cm (15%) | 7 cases (21%) |
| Edwards | 23 | 1,9 (range −1,5–5,1) | 12 limbs ≥ 2 cm (52%) | 10 cases (43%) |
| Schmalzried | 48 | N.A. | N.C. | N.C. |
| Simon et al. | 16 | N.A. | 3 limbs ≥ 2 cm (19%) | 2 cases (12%) (THRs) |
| Nercessian | 29 | 0,6 (range 0–2) | N.A. | 9 cases (31%) (THRs) |
| Pekkarinen | 27 | 1,4 (range 1–4,1) | 8 limbs ≥ 2 cm (30%) | 6 cases (22%) (THRs) |
| Park | 30 | 0,3 (range 0–2,5) | N.A. | 4 cases (13%) (THRs) |
N.A.: not available; N.C.: not clear.
Statistically significant recorded risk factors.
| Authors | Age | Gender | DDH | Previous hip surgery | Lengthening | Others |
|---|---|---|---|---|---|---|
| Weber |
| |||||
| Schmalzried | + | + | ||||
| Navarro | ||||||
| Oldenburg | + | |||||
| Pekkarinen | + | + | Fibrotic ankylosis after joint sepsis | |||
| Farrell | + | + | Posterior approach, cementless stem fixation | |||
| Park | + |
Prognosis of sciatic nerve injuries.
| Authors | Number of sciatic injuries | Follow-up | % complete lesions | Type of lesion | % full recovery |
|---|---|---|---|---|---|
| Weber | 10 | 1 Year | 100% | N.A. | 40% |
| Edwards | 23 | Mean 2.7 years | N.A. | 12 peroneal, 11 sciatic | 13% |
| Schmalzried | 48 | 12–198 ms | 73% | 26 peroneal, 19 sciatic, 3 tibial | N.C. |
| Simon et al. | 16 | N.C. | 0% | N.A. | 75% |
| Nercessian | 29 | Minimum 2 years | N.A. | 23 peroneal, 6 sciatic | 66% |
| Navarro | 7 | 1–2,5 years | N.A. | 6 peroneal, 1 sciatic | 14% |
| Oldenburg | 46 | Mean 107 months (11 to 240) | N.A. | 33 peroneal, 13 sciatic | N.C. |
| Pekkarinen | 27 | Mean 58 months (24 to 110) | 78% | 11 peroneal, 15 sciatic, 1 tibial | 63% |
| Farrell | 44 | Mean 6 years (0.2–21 ys) | 61% | 30 peroneal, 14 sciatic | 39% |
| Park | 30 | Mean 44,3 ms (3.7–114.4 ms) | 17% | 26 peroneal, 4 sciatic | 57% |
| Zappe | 9 | Mean 93 ms | 44% | N.A. | 67% |
Neurological deficit was followed until complete recovery or at least 2 years; N.A.: not available; N.C.: not clear.